Sep 20, 2022mandamusdengvaxiaright to healthseparation of powerssupreme courtadministrative law

Dengvaxia Mandamus Petition: Supreme Court on Judicial Power in Public Health Crises

Supreme Court dismisses Dengvaxia mandamus petition, ruling continuing mandamus is for environmental cases, not health rights disputes.


The Supreme Court, in Abines v. Duque (G.R. No. 235891, September 20, 2022), dismissed a petition for continuing mandamus filed by children who were inoculated with Dengvaxia, the dengue vaccine developed by Sanofi Pasteur. The decision clarifies the limits of judicial power in public health controversies, ruling that the writ of continuing mandamus is available only in environmental cases and cannot be used to compel discretionary executive acts. The ruling affirms that courts must respect the separation of powers, even when constitutional rights like the right to health are invoked.

Background of the Dengvaxia Vaccination Program

In December 2015, former President Benigno Aquino III and Health Secretary Janette Garin met with Sanofi Pasteur officials in Paris to discuss Dengvaxia, then expected to be the first vaccine against dengue. The Department of Health (DOH) subsequently procured millions of doses through a P3.5 billion Special Allotment Release Order, and a school-based vaccination program was implemented covering elementary students nine years old and above in several regions.

In November 2017, Sanofi Pasteur released updated information stating that Dengvaxia is only beneficial to those with prior dengue infection, and that those without prior infection may develop severe disease following vaccination upon subsequent infection. The DOH suspended the program on December 1, 2017, and the Food and Drug Administration suspended the vaccine's sale and distribution.

The Petition and Its Demands

Seventy-four children, represented by their parents, filed a Petition for Mandamus directly before the Supreme Court. They alleged that respondents—government officials involved in the vaccination program—failed to protect their right to health and used them as "guinea pigs" in an experiment. The petitioners prayed for the issuance of a writ of continuing mandamus ordering respondents to disseminate reports, conduct further studies on Dengvaxia's safety, create a registry of inoculated children, provide free medical services and treatment, and conduct free consultations.

The Court's Ruling on the Writ of Continuing Mandamus

The Supreme Court ruled that the petition must be dismissed. The Court emphasized that a petition for continuing mandamus "should mainly involve an environmental and other related law, rule, regulation, or a right therein." Since the petition invoked violations of the right to health—not ecological rights—the writ was not available to the petitioners.

Even assuming the writ could apply, the Court found the petition insufficient in substance. The acts sought by petitioners were not ministerial duties enjoined by law; they involved the exercise of judgment and discretion by executive officials. A writ of continuing mandamus should not be issued when it "directly or indirectly, substitutes judicial discretion for executive or legislative prerogatives."

Legal Standing and Hierarchy of Courts

The Court acknowledged that the petitioner-children had legal standing based on the direct injury they sustained from being inoculated with Dengvaxia. However, the petition still violated the doctrine of hierarchy of courts. While the Supreme Court shares original and concurrent jurisdiction with lower courts over petitions for continuing mandamus, litigants must first seek recourse from lower courts unless exceptional reasons are clearly and specifically pleaded.

The Court noted that resolving the petition required threshing out questions of fact and evaluating evidence—matters better suited for trial courts. Even the exceptions to the hierarchy doctrine, including transcendental importance and public welfare, could not save the petition because the questions presented were not purely legal.

Separation of Powers and Discretionary Acts

The Court underscored that mandamus will not lie against the executive branch for purely discretionary functions. Courts will not interfere with discretionary acts of the Executive unless there is grave abuse of discretion amounting to lack or excess of jurisdiction. The reliefs sought by petitioners—such as conducting further studies and creating a registry—involved judgment calls that belong to the DOH and other agencies with technical expertise.

The decision reaffirmed that the Judiciary cannot arrogate upon itself the power to oversee the entire bureaucracy. Unless there is a clear showing of constitutional infirmity or grave abuse of discretion, courts must yield to the doctrine of separation of powers.

Practical Takeaways

  • Continuing mandamus is for environmental cases. This writ, introduced in MMDA v. Concerned Residents of Manila Bay and incorporated in the Rules of Procedure for Environmental Cases, is not available for health rights disputes.
  • Mandamus cannot compel discretionary acts. Courts will only order a party to act, not to act in a particular way, when the act involves judgment and discretion.
  • Hierarchy of courts must be respected. Even in cases of transcendental importance, parties should first file before lower courts when factual questions must be resolved.
  • Judicial restraint applies in public health crises. Courts defer to executive agencies' technical expertise unless there is grave abuse of discretion.
  • Direct injury confers standing, but standing alone is insufficient. Petitioners must also comply with procedural rules and substantive requirements for the relief sought.

This article is general information and not legal advice. For your specific situation, consult a lawyer or ask ASG Legal AI.

This article is general information and not legal advice. For your situation, ask ASG Legal AI or book a consultation.